You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 4, July 22, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Are intravenous corticosteroids required in status asthmaticus?

D. Ratto, C. Alfaro, J. Sipsey, M. M. Glovsky and O. P. Sharma
Department of Pulmonary Medicine, Los Angeles County, University of Southern California Medical Center 90033.

Seventy-seven patients with status asthmaticus were prospectively studied to compare oral with intravenous methylprednisolone. Patients were given methylprednisolone, either 160 or 320 mg orally or 500 or 1000 mg intravenously, daily in equally divided doses. They were randomly assigned to either group on a daily sequential basis. Spirometry was performed within one hour of the initial dose of steroids. The mean presenting forced expiratory volume in 1 s was 26% of the predicted value. Spirometry was then repeated every six hours for the first 24 hours and then every eight to 12 hours until discharge or 72 hours, whichever occurred first. There were no significant differences in the incidence of respiratory failure, forced expiratory volume in 1 s, days of hospitalization, rate of improvement in pulmonary function, or side effects. No patient who went into respiratory failure did so more than three hours after receiving the initial dose of steroids. We conclude that oral methylprednisolone is safe and effective in the treatment of status asthmaticus.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Global strategy for asthma management and prevention: GINA executive summary
Bateman et al.
Eur Respir J 2008;31:143-178.
ABSTRACT | FULL TEXT  

Oral or IV Prednisolone in the Treatment of COPD Exacerbations: A Randomized, Controlled, Double-blind Study
de Jong et al.
Chest 2007;132:1741-1747.
ABSTRACT | FULL TEXT  

Part 10.5: Near-Fatal Asthma
Circulation 2005;112:IV-139-IV-142.
FULL TEXT  

Acute Severe Asthma
McFadden
Am. J. Respir. Crit. Care Med. 2003;168:740-759.
ABSTRACT | FULL TEXT  

Randomised pragmatic comparison of UK and US treatment of acute asthma presenting to hospital
Innes et al.
Thorax 2002;57:1040-1044.
ABSTRACT | FULL TEXT  

Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis
Metz et al.
Neurology 1999;53:2093-2093.
ABSTRACT | FULL TEXT  

Corticosteroids in Acute Respiratory Failure
JANTZ and SAHN
Am. J. Respir. Crit. Care Med. 1999;160:1079-1100.
FULL TEXT  

Corticosteroids in the Emergency Department Therapy of Acute Adult Asthma: An Evidence-Based Evaluation
Rodrigo and Rodrigo
Chest 1999;116:285-295.
ABSTRACT | FULL TEXT  

Emergency Department and Hospital Treatment of Asthma
Tsiu and Self
Journal of Pharmacy Practice 1992;5:177-185.
ABSTRACT  

Status Asthmaticus
Jederlinic and Irwin
J Intensive Care Med 1989;4:166-184.
 

USE OF INTRAVENOUS STEROIDS FOR ASTHMA CHALLENGED
JWatch General 1988;1988:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.